An interventional study of trans rectus sheath extra-peritoneal procedure (TREPP) in Inguinal Hernia and Inguinal Hernia Repair, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-01.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Hernia, Inguinal by Assiut University — 9 open to participants now, 9 under way, none of them phase 3. Hernia, Inguinal · Assiut University.
Among the 12 studies in Hernia, Inguinal by Assiut University, this one is the 7th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 10th registered.
545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.
Browse Hernia, Inguinal studies →9 of the 12 studies in Hernia, Inguinal by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Ages 18+ · Men only
Assiut University
Ages 18+
Assiut University
Ages 18–65
Assiut University
Ages 1 mo–18 yrs
Assiut University
Ages 18–50
By country, each count listing its studies:
Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 60 across the 10 interventional studies, 25 across the 2 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Hernia, Inguinal by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06258317Assiut UniversityMesh Fixation Versus Non Fixation in Laparoscopic Inguinal Hernioplasty | 2027-02 |
| NCT07837492Assiut UniversityUltrasound-Guided Ilioinguinal-Iliohypogastric Nerve Block Following Spinal Anesthesia Comparing Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Unilateral Inguinal Hernia Repair | 2027-10 |
| NCT07910240Assiut UniversityBassini Repair Versus Desarda Technique in Urgent Complicated Inguinal Hernia Repair | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 12 studies in Hernia, Inguinal by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Inguinal hernia repair remains one of the most commonly performed surgical procedures worldwide. Tension-free repair with mesh augmentation is the predominant treatment option, either achieved by preperitoneal laparoscopic hernioplasty or Lichtenstein procedure (LP). As the recurrence rate is reduced to less than 5 % after mesh repair, nowadays, long-term morbidity associated with open inguinal hernia repair is mainly related to chronic postoperative inguinal pain (CPIP). Despite many hypotheses about the possible causes for CPIP, there is now consensus that involvement of inguinal nerves plays a major role.
The trans rectus sheath extra-peritoneal procedure (TREPP) is a minimally invasive open approach utilizing the rectus sheath to access the preperitoneal space. It has shown promise in providing effective repair with potential advantages in cosmesis, postoperative pain, and recurrence rates. It is a medial approach avoiding the interference with the course of all (three) inguinal nerves through lateral abdominal wall.
This is a prospective cohort study
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients undergoing TransREctus Sheath PrePeritoneal Procedure (TREPP) for inguinal hernia repair
Procedure: trans rectus sheath extra-peritoneal procedure (TREPP)
The TREPP technique, a minimally invasive open approach utilizing the rectus sheath to access the preperitoneal space
Recurrence rate
Number and percentage of patients with recurrence of hernia after surgery
Time frame: through study completion, an average of 1 year
Incidence of chronic postoperative inguinal pain
Number and percentage of patients with groin pain that lasts more than three months after inguinal hernia surgery
Time frame: 3 months after surgery
Plan to share: No
Started Apr 2025 (actual). Primary completion is estimated for Jun 2026, 14 months after the start.
Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 14 months is below that.
Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.